跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,107 条关于
“pemphigus vulgaris”
全部
1,107
临床试验
1,013
药物
39
机构
0
资讯
55
11个月前
Cabaletta Bio's CAR-T Therapy Shows Promise Without Preconditioning in Pemphigus Vulgaris Trial
10个月前
Scientists Successfully Reprogram Pathogenic T Cells Into Protective Regulatory Cells for Autoimmune Disease Treatment
去年
Patient Enrollment Concluded Early in PEGASUS Phase 3 Pemphigus Trial for Rilzabrutinib
去年
Cabaletta Bio to Present New CABA-201 Clinical Data at ACR Convergence 2024
去年
Dr. Reddy's Rituximab Biosimilar Receives Positive CHMP Opinion for EU Launch
去年
FDA Grants Fast Track Designation to Artiva's AlloNK Cell Therapy for Autoimmune Diseases
2年前
Novartis' Ianalumab Advances in Phase 3 Trial for Lupus Nephritis as CDSCO Approves Protocol Amendment
去年
Cabaletta Bio Announces Positive Clinical Updates for CABA-201 in Autoimmune Diseases
去年
Cabaletta Bio's Rese-cel Shows Promising Safety and Efficacy in Autoimmune Disease Trials
去年
Artiva Biotherapeutics Announces AlloNK® Clinical Updates and Q3 2024 Financial Results
第 1 页,共 6 页
上一页
下一页